NCT00924040 2015-10-29
Retreatment Protocol for BL22 Immunotherapy in Relapsed or Refractory Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)